ABBOTT LABORATORIES
For the period ended Oct 21, 2026. Filed Oct 21, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 21, 2026 · Filed Oct 21, 2026
Use the contents to explore the available documents and sections.
ABT$109.93-3.2%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · When will the separation be complete?
When will the separation be complete?
Abbott expects to complete the transaction by the end of 2027, subject to customary conditions, including regulatory approvals, the effectiveness of a registration statement on Form 10 and final approval by the Abbott Board of Directors.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.